✦ LIBER ✦

Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor

✍ Scribed by Ogiwara, Kenichi; Nogami, Keiji; Matsumoto, Tomoko; Shima, Midori

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of activated prothrombin complex con

✍ Garehime, W.J.; Pecaro, B.C.; Green, D. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Sequential therapy with activated prothr

✍ J. Schneiderman; D. J. Nugent; G. Young 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Incidence of inhibitors in patients with

✍ Dr. Iise Schwarzinger; Ingrid Pabinger; Christian Korninger; Ferdinand Haschke; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 2 views

Sequential therapy with activated prothr

✍ M. ECONOMOU; A. TELI; A. TZANTZAROUDI; I. TSATRA; A. ZAVITSANAKIS; M. ATHANASSIO 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Sequential therapy with activated prothr

✍ J. SCHNEIDERMAN; E. RUBIN; D. J. NUGENT; G. YOUNG 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

PSY1 A SYSTEMATIC REVIEW OF THE EFFICACY

✍ C Knight; AM Dano; T Kennedy-Martin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB